Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Sep 15, 2019; 11(9): 665-678
Published online Sep 15, 2019. doi: 10.4251/wjgo.v11.i9.665
Published online Sep 15, 2019. doi: 10.4251/wjgo.v11.i9.665
Figure 2 Graphical representation of selected large studies investigating progression/regression of premalignant gastric lesions across the stages of the Correa cascade.
Arrows represent the direction of effect findings, with the size of the arrow the strength of effect (not to scale between cohorts and only major findings of trials represented). H. pylori Rx: Helicobacter pylori antibiotic therapy; CIM: Complete IM; IIM: Incomplete IM; LGD: Low-grade dysplasia; HGD: High-grade dysplasia; IM: Intestinal metaplasia.
- Citation: Koulis A, Buckle A, Boussioutas A. Premalignant lesions and gastric cancer: Current understanding. World J Gastrointest Oncol 2019; 11(9): 665-678
- URL: https://www.wjgnet.com/1948-5204/full/v11/i9/665.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i9.665